Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diclofenac | 3 | 2013 | 71 | 0.610 |
Why?
|
| beta-Cyclodextrins | 2 | 2013 | 64 | 0.480 |
Why?
|
| Excipients | 2 | 2013 | 96 | 0.470 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2013 | 2279 | 0.310 |
Why?
|
| Vagina | 2 | 2019 | 825 | 0.180 |
Why?
|
| Phosphoproteins | 5 | 1996 | 2440 | 0.170 |
Why?
|
| Pain, Postoperative | 4 | 2011 | 1640 | 0.160 |
Why?
|
| Ketamine | 1 | 2004 | 500 | 0.160 |
Why?
|
| Tooth Extraction | 2 | 2011 | 222 | 0.150 |
Why?
|
| Analgesics | 1 | 2004 | 1040 | 0.140 |
Why?
|
| Atrophy | 2 | 2019 | 1582 | 0.140 |
Why?
|
| Tamoxifen | 1 | 2019 | 981 | 0.120 |
Why?
|
| Morphine | 2 | 2008 | 657 | 0.120 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 2032 | 0.120 |
Why?
|
| PUVA Therapy | 2 | 1993 | 98 | 0.120 |
Why?
|
| Biological Availability | 1 | 2013 | 396 | 0.110 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 548 | 0.100 |
Why?
|
| RNA Polymerase II | 3 | 1998 | 551 | 0.100 |
Why?
|
| Area Under Curve | 2 | 2013 | 1655 | 0.100 |
Why?
|
| Ketorolac | 1 | 2011 | 77 | 0.090 |
Why?
|
| Infusions, Intravenous | 2 | 2013 | 2272 | 0.090 |
Why?
|
| Administration, Intranasal | 3 | 2008 | 446 | 0.090 |
Why?
|
| Estriol | 1 | 2009 | 54 | 0.090 |
Why?
|
| Vaginitis | 1 | 2009 | 47 | 0.090 |
Why?
|
| Toothache | 1 | 2008 | 34 | 0.080 |
Why?
|
| Pain | 1 | 2004 | 4987 | 0.080 |
Why?
|
| Transcription Factors | 7 | 1998 | 12207 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2013 | 3913 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 1996 | 3023 | 0.080 |
Why?
|
| Transcription, Genetic | 7 | 1998 | 7723 | 0.070 |
Why?
|
| Analgesics, Opioid | 3 | 2008 | 3674 | 0.070 |
Why?
|
| Tyrosine | 1 | 1991 | 1461 | 0.070 |
Why?
|
| Administration, Intravaginal | 2 | 2019 | 150 | 0.060 |
Why?
|
| Progesterone | 1 | 2009 | 776 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1996 | 3617 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1991 | 2455 | 0.060 |
Why?
|
| Epidermal Growth Factor | 3 | 1991 | 709 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10949 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 1203 | 0.050 |
Why?
|
| Injections, Intravenous | 3 | 2011 | 1420 | 0.050 |
Why?
|
| Genes, MHC Class II | 2 | 1994 | 457 | 0.050 |
Why?
|
| Double-Blind Method | 5 | 2011 | 12035 | 0.050 |
Why?
|
| Postmenopause | 1 | 2009 | 2461 | 0.050 |
Why?
|
| Placebos | 1 | 2004 | 1677 | 0.040 |
Why?
|
| HeLa Cells | 5 | 1996 | 3129 | 0.040 |
Why?
|
| Orthopedic Procedures | 1 | 2008 | 1288 | 0.040 |
Why?
|
| Chitosan | 2 | 2008 | 141 | 0.040 |
Why?
|
| Macromolecular Substances | 2 | 1996 | 1456 | 0.030 |
Why?
|
| Transcription Factors, TFII | 1 | 1995 | 60 | 0.030 |
Why?
|
| Cloning, Molecular | 3 | 1996 | 4321 | 0.030 |
Why?
|
| Amino Acid Sequence | 6 | 1998 | 13817 | 0.030 |
Why?
|
| Pain Measurement | 3 | 2011 | 3419 | 0.030 |
Why?
|
| Molecular Weight | 3 | 1993 | 2255 | 0.030 |
Why?
|
| DNA Primers | 2 | 1996 | 2892 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1996 | 2839 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2886 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1995 | 549 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 9275 | 0.030 |
Why?
|
| Molecular Sequence Data | 6 | 1996 | 18116 | 0.030 |
Why?
|
| Base Sequence | 5 | 1996 | 12801 | 0.030 |
Why?
|
| Rabbits | 1 | 2019 | 4892 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1992 | 1801 | 0.030 |
Why?
|
| Tyrphostins | 1 | 1991 | 67 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1996 | 2256 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1995 | 671 | 0.020 |
Why?
|
| Catechols | 1 | 1991 | 61 | 0.020 |
Why?
|
| Haptens | 1 | 1991 | 166 | 0.020 |
Why?
|
| Molar, Third | 1 | 2011 | 49 | 0.020 |
Why?
|
| Adult | 6 | 2013 | 214035 | 0.020 |
Why?
|
| Female | 9 | 2019 | 380197 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 918 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 1993 | 2050 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 1991 | 457 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 462 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2004 | 9147 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1991 | 1095 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1989 | 821 | 0.020 |
Why?
|
| Pharmaceutical Solutions | 1 | 2008 | 15 | 0.020 |
Why?
|
| Humans | 18 | 2013 | 744220 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 1989 | 5867 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1989 | 362 | 0.020 |
Why?
|
| DNA-Binding Proteins | 4 | 1998 | 9647 | 0.020 |
Why?
|
| Phosphorylation | 4 | 1995 | 8437 | 0.020 |
Why?
|
| Cell Line | 3 | 1991 | 15999 | 0.020 |
Why?
|
| Male | 7 | 2013 | 350027 | 0.020 |
Why?
|
| Hallux Valgus | 1 | 2008 | 65 | 0.020 |
Why?
|
| Immunity | 1 | 1993 | 1012 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1996 | 2969 | 0.020 |
Why?
|
| Molar | 1 | 2007 | 152 | 0.020 |
Why?
|
| Thrombophlebitis | 1 | 2007 | 309 | 0.020 |
Why?
|
| Nitriles | 1 | 1991 | 952 | 0.020 |
Why?
|
| Transcription Factor TFIIB | 2 | 1998 | 24 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1989 | 794 | 0.020 |
Why?
|
| Histones | 1 | 1996 | 2600 | 0.020 |
Why?
|
| TATA-Box Binding Protein | 2 | 1998 | 98 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1989 | 1099 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 1962 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1993 | 2617 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2009 | 63119 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1989 | 1227 | 0.020 |
Why?
|
| Safety | 1 | 2009 | 1185 | 0.020 |
Why?
|
| Animals | 6 | 2019 | 168788 | 0.010 |
Why?
|
| Recombinant Proteins | 4 | 1995 | 6612 | 0.010 |
Why?
|
| Protein Binding | 1 | 1996 | 9392 | 0.010 |
Why?
|
| Transcription Factor TFIIA | 2 | 1993 | 17 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 3871 | 0.010 |
Why?
|
| DNA | 3 | 1998 | 7303 | 0.010 |
Why?
|
| Aged | 4 | 2011 | 163253 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6367 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 6386 | 0.010 |
Why?
|
| Psoriasis | 1 | 1989 | 898 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1996 | 13036 | 0.010 |
Why?
|
| Binding Sites | 1 | 1989 | 6116 | 0.010 |
Why?
|
| Middle Aged | 4 | 2011 | 213367 | 0.010 |
Why?
|
| Adolescent | 4 | 2011 | 85759 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6535 | 0.010 |
Why?
|
| Rats | 1 | 1996 | 24273 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6485 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 1994 | 12075 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 8321 | 0.010 |
Why?
|
| Cyclin H | 1 | 1995 | 5 | 0.010 |
Why?
|
| Transcription Factor TFIIH | 1 | 1995 | 30 | 0.010 |
Why?
|
| Sarcosine | 1 | 1995 | 16 | 0.010 |
Why?
|
| Protein Kinases | 2 | 1995 | 1639 | 0.010 |
Why?
|
| Blotting, Western | 2 | 1993 | 5180 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1995 | 218 | 0.010 |
Why?
|
| Detergents | 1 | 1995 | 230 | 0.010 |
Why?
|
| TATA Box | 1 | 1994 | 128 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1998 | 1246 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1998 | 914 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1993 | 305 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1994 | 2752 | 0.010 |
Why?
|
| Cyclins | 1 | 1995 | 603 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 964 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 20817 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1992 | 829 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15538 | 0.010 |
Why?
|
| Adenovirus Early Proteins | 1 | 1989 | 57 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1989 | 103 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1989 | 427 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 26413 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1989 | 718 | 0.010 |
Why?
|
| Quality of Life | 1 | 2009 | 12805 | 0.000 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1989 | 337 | 0.000 |
Why?
|
| Antigens | 1 | 1993 | 1466 | 0.000 |
Why?
|
| Models, Molecular | 1 | 1998 | 5458 | 0.000 |
Why?
|
| Mice | 2 | 1993 | 81178 | 0.000 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1989 | 514 | 0.000 |
Why?
|
| Epitopes | 1 | 1993 | 2571 | 0.000 |
Why?
|
| Molecular Structure | 1 | 1991 | 1907 | 0.000 |
Why?
|
| Biological Transport | 1 | 1991 | 2120 | 0.000 |
Why?
|
| Interleukin-2 | 1 | 1993 | 1904 | 0.000 |
Why?
|
| Time Factors | 1 | 2007 | 40063 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1991 | 3701 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1994 | 3420 | 0.000 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 1269 | 0.000 |
Why?
|
| Trans-Activators | 1 | 1994 | 2924 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 56436 | 0.000 |
Why?
|
| Cell Division | 1 | 1991 | 4567 | 0.000 |
Why?
|
| Kinetics | 1 | 1991 | 6474 | 0.000 |
Why?
|
| Cell Survival | 1 | 1993 | 5881 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1993 | 5523 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1992 | 4220 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1993 | 10182 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1991 | 4033 | 0.000 |
Why?
|
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_